Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites
Sign Up to like & getrecommendations! Published in 2025 at "Liver Transplantation"
DOI: 10.1097/lvt.0000000000000623
Abstract: Refractory ascites often requires therapeutic paracentesis, which is associated with potential risks and diminished quality of life. Terlipressin is a vasopressin analog that is indicated for i.v. bolus injection for hepatorenal syndrome, with the potential… read more here.
Keywords: refractory ascites; terlipressin; infusion; biv201 ... See more keywords